Cannabis & Wellness

The Swedish health firm reports a 51% revenue surge and record profits, fueled by a string of strategic acquisitions aimed at dominating the Americas.

Pioneering clean beauty brand Indie Lee launches an affordable new line, Indie Lee Botanicals, exclusively at Whole Foods Market, making quality skincare accessible.

A pivotal trial for a rare muscle disease failed its main goal, but promising data in a specific patient group offers a new, complex path forward.

The cannabis giant upsizes its credit facility by CAD $15M, signaling strong lender confidence and fueling its ambitious global expansion plans.

The hydration expert launches a new line of functional drink mixes for cravings, immunity, and energy, tapping into the booming wellness market.

UK brand Aurelia Cellular Vitality launches in the US, betting its science-led Eternacell™ complex can disrupt the booming ingestible beauty industry.

A major real-world study shows physician-led medical cannabis use improves pain, anxiety, and quality of life, adding key evidence to the field.

Chinese skincare firm Park Ha secures fresh capital for expansion, but a plunging stock and complex warrants create a high-risk scenario for investors.

77% of Americans take supplements, but most are wasted. A new company claims its science can deliver nutrients up to 149x more effectively.

A new study is tracking how chia seeds and daily stress impact the microbiome, aiming to unlock the future of data-driven, personalized nutrition.

O Positiv's new menopause and metabolism products at Target signal a market shift. But how strong is the science behind these 'clinically studied' formulas?

Prenetics slashed future dilution risk by exchanging 4.7M warrants, a move analysts see as crucial for fueling the rapid growth of its IM8 wellness brand.

Cannara Biotech rockets to #1 in Québec's cannabis market, fueled by a smash-hit vape launch, while also moving to overhaul its corporate governance.

Interim CFO Donna Granato's departure marks a pivotal moment for Ayr Wellness as it completes a massive debt restructuring and transitions to a new entity.

A monumental shift in U.S. drug policy as cannabis is rescheduled. See what this means for Verano, Wall Street, and the future of the industry.

Medical cannabis firm Crucial Innovations retains FOCUS Capital Partners, signaling a push for institutional investment and a potential 2026 US listing.

Recent CPSC warnings reveal deadly products on the market. As regulators struggle with e-commerce, can AI become the tool we need to stop them?